These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9384917)

  • 21. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF; Fellerer K; Fichte K; Fischer G; Geyer N; Meya U; Sastre-y-Hernández M; Schöny W; Schratzer M; Soukop W
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1985 Feb; 142(2):155-62. PubMed ID: 3881999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative clinical experiences with Protriptyline in depressive conditions of various origins].
    Angst J; Poeldinger W
    Arzneimittelforschung; 1966 Jul; 16(7):893-6. PubMed ID: 6014720
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states.
    Ogura C; Okuma T; Uchida Y; Imai S; Yogi H
    Folia Psychiatr Neurol Jpn; 1974; 28(3):179-86. PubMed ID: 4435675
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship between antidepressant partial and nonresponse and subsequent response to antidepressant augmentation.
    Joffe RT; Levitt AJ
    J Affect Disord; 1999; 52(1-3):257-9. PubMed ID: 10357043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of pharmacotherapy of major depression in children and adolescents.
    Ambrosini PJ
    Psychiatr Serv; 2000 May; 51(5):627-33. PubMed ID: 10783181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of adolescent major depression: beyond TCAs.
    Ryan ND
    Psychopharmacol Bull; 1990; 26(1):75-9. PubMed ID: 2196629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D; Mattes J; Sheehan KH; Sheehan DV
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing Pattern of Antidepressants in Children and Adolescents: Findings from the Research on Asia Psychotropic Prescription Pattern.
    Chee KY; Tripathi A; Avasthi A; Chong MY; Xiang YT; Sim K; Kanba S; He YL; Lee MS; Chiu HF; Yang SY; Kuga H; Udomratn P; Tanra AJ; Maramis MM; Grover S; Mahendran R; Kallivayalil RA; Shen WW; Shinfuku N; Tan CH; Sartorius N
    East Asian Arch Psychiatry; 2016 Mar; 26(1):10-7. PubMed ID: 27086755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
    [No Abstract]   [Full Text] [Related]  

  • 36. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K; London J; Fox I; Hassman H; Csanalosi I; Weise C
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo.
    Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
    Psychopharmacol Bull; 1989; 25(2):272-6. PubMed ID: 2532374
    [No Abstract]   [Full Text] [Related]  

  • 38. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipramine in prepubertal major depressive disorders.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Tabrizi MA; King J; Goetz R; Davies M; Stiller RL
    Arch Gen Psychiatry; 1987 Jan; 44(1):81-9. PubMed ID: 3541830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.